熱門資訊> 正文
FibroBiologics计划销售180万台
2024-04-27 03:23
- FibroBiologics (NASDAQ:FBLG) filed a prospectus related to the sale of 1.8M units at an assumed public offering price of $11.1 per unit.
- Each unit consists of one share, and one warrant to buy one share.
- This preliminary prospectus is not an offer to sell these securities.
More on FibroBiologics, Inc.
- FibroBiologics reports encouraging early data for diabetes cell therapy
- FibroBiologics stock rallies 82% amid data presentation, SEC filing
- Financial information for FibroBiologics, Inc.
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。